Literature DB >> 3411310

Failure of influenza vaccination in the aged.

G Keren1, S Segev, A Morag, Z Zakay-Rones, A Barzilai, E Rubinstein.   

Abstract

A cohort of 127 nursing home residents aged 60-98 years were vaccinated during the winter of 1985-86 with the A-Chile 1/83 (C), A-Philippines 2/82 (P), and B-USSR (B) commercial influenza vaccines. Before vaccination 40%, 23%, and 69% were susceptible to influenza Ac, Ap, and B, respectively [hemagglutinin inhibition (H.I.) titer less than 1:40]. One month following initial vaccination, 32 patients [25%] remained unprotected against two or all three vaccine strains. These patients were revaccinated with the same influenza vaccine and followed up. At five months 11%, 19%, and 23% of the initial cohort were still unprotected against Ac, Ap, and B strains, respectively. We conclude that two conventional influenza vaccines administered one month apart leave unprotected 30% of healthy elderly people who are initial influenza vaccine failures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411310     DOI: 10.1002/jmv.1890250112

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Efficacy of the influenza vaccine in patients with malignant lymphoma.

Authors:  Joseph J Mazza; Steven H Yale; Jodi R Arrowood; Cory E Reynolds; Ingrid Glurich; Po-Huang Chyou; James G Linneman; Kurt D Reed
Journal:  Clin Med Res       Date:  2005-11

Review 2.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 3.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 4.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

6.  CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly.

Authors:  Laura Haynes; Sheri M Eaton; Eve M Burns; Troy D Randall; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 7.  Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors.

Authors:  H Van Loveren; J G Van Amsterdam; R J Vandebriel; T G Kimman; H C Rümke; P S Steerenberg; J G Vos
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

8.  Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.

Authors:  Jiu Jiang; Erin M Fisher; Scott E Hensley; Sara Lustigman; Donna M Murasko; Hao Shen
Journal:  Vaccine       Date:  2014-03-26       Impact factor: 3.641

9.  Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice.

Authors:  Mayra García; Julia A Misplon; Graeme E Price; Chia-Yun Lo; Suzanne L Epstein
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

10.  Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011.

Authors:  Deliana Kostova; Carrie Reed; Lyn Finelli; Po-Yung Cheng; Paul M Gargiullo; David K Shay; James A Singleton; Martin I Meltzer; Peng-Jun Lu; Joseph S Bresee
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.